Beijing Tong Ren Tang Chinese Medicine Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: HK0000145638
HKD
8.61
-0.05 (-0.58%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'17
Sep'17
Jun'17
Mar'17
Dec'16
Sep'16
Jun'16
Net Sales
329.76
312.46
308.75
315.03
276.04
266.29
276.63
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
329.76
312.46
308.75
315.03
276.04
266.29
276.63
Raw Material Cost
95.65
90.23
86.42
77.26
76.96
70.56
72.11
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
40.96
0.00
0.00
0.00
34.16
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.01
0.01
0.04
0.01
0.01
0.01
Selling and Distribution Expenses
102.89
72.18
74.79
70.89
91.37
63.65
57.77
Other Expenses
-0.00
-0.00
-4.10
-0.00
-0.00
-0.00
-3.42
Total Expenditure (Excl Depreciation)
198.54
162.41
161.22
148.15
168.33
134.21
129.88
Operating Profit (PBDIT) excl Other Income
131.2
150
147.5
166.9
107.69999999999999
132.10000000000002
146.8
Other Income
3.90
4.77
3.28
3.46
3.18
2.25
3.77
Operating Profit (PBDIT)
135.12
154.82
157.06
170.34
110.88
134.33
156.40
Interest
0.01
0.01
0.01
0.04
0.01
0.01
0.01
Exceptional Items
0.00
0.00
0.00
0.00
-1.29
0.00
0.00
Gross Profit (PBDT)
234.11
222.23
222.32
237.77
199.08
195.73
204.52
Depreciation
0.00
0.00
6.25
0.00
0.00
0.00
5.87
Profit Before Tax
135.11
154.81
150.80
170.29
109.58
134.31
150.51
Tax
23.79
26.64
22.28
32.74
17.16
25.58
24.70
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
107.86
124.76
124.80
132.55
86.48
105.28
120.14
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
107.86
124.76
124.80
132.55
86.48
105.28
120.14
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.46
3.41
3.73
4.95
6.30
2.76
5.13
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
111.32
128.17
128.52
137.50
92.79
108.04
125.26
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,492.89
0.00
2,255.12
0.00
2,122.54
0.00
1,937.87
Earnings per share (EPS)
0.13
0.15
0.15
0.16
0.1
0.13
0.14
Diluted Earnings per share
0.13
0.15
0.15
0.16
0.1
0.13
0.14
Operating Profit Margin (Excl OI)
39.79%
48.02%
47.78%
52.97%
39.02%
49.6%
53.05%
Gross Profit Margin
40.97%
49.55%
50.87%
54.06%
39.7%
50.44%
56.53%
PAT Margin
32.71%
39.93%
40.42%
42.08%
31.33%
39.54%
43.43%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2017 is 19.49% vs 8.19% in Dec 2016

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2017 is 19.94% vs -10.34% in Dec 2016

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2017 is 21.82% vs -11.29% in Dec 2016

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2017 has improved from Dec 2016

Compare Quarterly Results Of Beijing Tong Ren Tang Chinese Medicine Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
329.76
76,201.97
-75,872.21
-99.57%
Other Operating Income
0.00
0.00
0.00
Total Operating income
329.76
76,201.97
-75,872.21
-99.57%
Raw Material Cost
95.65
68,628.65
-68,533.00
-99.86%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.01
478.69
-478.68
-100.00%
Selling and Distribution Expenses
102.89
4,894.70
-4,791.81
-97.90%
Other Expenses
-0.00
-5.69
5.69
100.00%
Total Expenditure (Excl Depreciation)
198.54
73,945.09
-73,746.55
-99.73%
Operating Profit (PBDIT) excl Other Income
131.22
2,256.87
-2,125.65
-94.19%
Other Income
3.90
3,518.93
-3,515.03
-99.89%
Operating Profit (PBDIT)
135.12
6,082.51
-5,947.39
-97.78%
Interest
0.01
478.69
-478.68
-100.00%
Exceptional Items
0.00
40.95
-40.95
-100.00%
Gross Profit (PBDT)
234.11
7,573.32
-7,339.21
-96.91%
Depreciation
0.00
785.40
-785.40
-100.00%
Profit Before Tax
135.11
4,859.38
-4,724.27
-97.22%
Tax
23.79
1,417.38
-1,393.59
-98.32%
Provisions and contingencies
0.00
0
0.00
Profit After Tax
107.86
3,372.98
-3,265.12
-96.80%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
107.86
3,372.98
-3,265.12
-96.80%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
3.46
246.89
-243.43
-98.60%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
111.32
3,619.87
-3,508.55
-96.92%
Equity Capital
0
0
0.00
Face Value
0.00
1.10
0.00
Reserves
2,492.89
82,269.33
-79,776.44
-96.97%
Earnings per share (EPS)
0.13
0.91
-0.78
-85.71%
Diluted Earnings per share
0.13
0.91
-0.78
-85.71%
Operating Profit Margin (Excl OI)
39.79%
2.33%
0.00
37.46%
Gross Profit Margin
40.97%
7.41%
0.00
33.56%
PAT Margin
32.71%
4.43%
0.00
28.28%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 32.98 Million
in Dec 2017

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2017 is 5.54% vs 1.23% in Sep 2017

stock-summary

YoY Growth in quarter ended Dec 2017 is 19.49% vs 8.19% in Dec 2016

Quarterly - Consolidate Net Profit
Consolidate Net Profit 11.13 Million
in Dec 2017

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2017 is -13.18% vs -0.23% in Sep 2017

stock-summary

YoY Growth in quarter ended Dec 2017 is 19.94% vs -10.34% in Dec 2016

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.12 Million
in Dec 2017

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2017 is -12.53% vs -2.47% in Sep 2017

stock-summary

YoY Growth in quarter ended Dec 2017 is 21.82% vs -11.29% in Dec 2016

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 39.79%
in Dec 2017

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2017 has fallen from Sep 2017

stock-summary

YoY Growth in quarter ended Dec 2017 has improved from Dec 2016